AI주식인사이트AI Stock Insight
C

녹십자홀딩스

005250KOSPI회사 본부 및 경영 컨설팅 서비스업

44.0 / 100

Reference Date: 2026-04-13

Financial Score13.5 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, ROE is below the industry average. Slightly down 2.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Samsung Biologics Holdings Co., Ltd. is a holding company established in 2001, managing 54 subsidiaries across five business segments, including pharmaceuticals, diagnostics, and healthcare services. While the holding company oversees strategic planning and portfolio management, subsidiaries handle operational activities. The company has expanded its domestic and international revenue and asset base.

Number of Employees

163people

Average Salary

78.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 5.244.0Point
PBR
0.37Industry Average 0.362.5Point

Higher than industry avg (caution)

ROE
-2.31Industry Average 4.780.0Point

Well below industry avg

Debt Ratio
39.54Industry Average 29.292.0Point

Higher than industry avg (caution)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲236.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -2.2% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 0Neutral 2Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position3.0Point

52w lower range (24%)

Current 13,800Won52-week high 17,20052-week low 12,680
1-month return2.0Point

1m -2.06% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0
  • Neutral주식등의대량보유상황보고서(약식)2026-04-01
  • Neutral타법인주식및출자증권취득결정2026-03-31
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
  • Neutral정기주주총회결과2026-03-26
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-23